๐ฐ Alkermes News
Page 39 - Alkermes News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Alkermes. Real-time updates on events, politics, business and more.
April 26, 2023
/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today reported financial results for the first quarter of 2023....
April 26, 2023
NORTHAMPTON, MA / ACCESSWIRE / April 26, 2023 / Patients diagnosed with platinum-resistant Ovarian Cancer (PROC) often face poor prognosis due to the limited treatment options. Watch this video to learn
April 25, 2023
DUBLIN, April 25, 2023 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced that on April 19, 2023 it received a second interim award (the "Second Interim Award") from the arbitral tribunal
April 25, 2023
Katie Joyce, our VP of Corporate Affairs is participated in a panel discussion at this yearโs Women In Bio - Engage. Educate. Empower.
April 25, 2023
Alkermes plc (NASDAQ:ALKS – Get Rating)’s share price traded up 3.4% on Tuesday after JPMorgan Chase & Co. raised their price target on the stock from $29.00 to $31.00. The stock traded as high as $30.27 and last traded at $30.18. 1,538,199 shares traded hands during trading, an increase of 18% from the average session […]
April 25, 2023
Item 7.01 Regulation FD Disclosure. On April 25, 2023, Alkermes plc issued a press release related to the matter described in this Current Report on Form 8-K, a copy of which is furnished herewith... | April 25, 2023
April 25, 2023
Ursula A. Matulonis highlights previous data from the phase 3 ENGOT-OV16/NOVA trial initial readout and subsequent preplanned overall survival analysis, discusses new findings from the final analysis, and emphasizes how these data clarify some of the studyโs limitations and reinforce the importance of adhering to the adjusted FDA label for niraparib in recurrent ovarian cancer.
April 22, 2023
Profund Advisors LLC grew its stake in Alkermes plc (NASDAQ:ALKS – Get Rating) by 2.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 22,216 shares of the company’s stock after purchasing an additional 437 shares during the period. Profund Advisors LLC’s holdings […]
April 21, 2023
DUBLIN / ACCESSWIRE / April 21, 2023 / Alkermes plc (Nasdaq:ALKS) recently announced that the company will accept applications for its Alkermes Inspiration Grants® program beginning on May 1, 2023. Now
April 21, 2023
Alkermes Announces Application Period for 2023 Alkermes Inspiration ...